Novel Sustainable Nanocarrier Systems for Improving Drug Efficacy
DOI:
https://doi.org/10.56511/JIPBS.2015.v2.i03.pp322-332Abstract
The privilege of delivering the drug parenterally in an implantable nanocarrier (IN) system was compared with a previously studied transdermal nanoemulsion (NE) drug delivery system in order to enhance the drug efficacy in terms of dose, frequency and patient compliance over its oral dosage form. These nanocarrier systems were evaluated by studying their drug loading and entrapment efficiency, in vitro release and characterization including particle size and morphology, pH range and viscosity measurements. Both of these systems possessed optimum droplet size, polydispersity and viscosity with a promising release and permeation properties and characterized by their patient friendly nonirritant property due to their compatible pH values with human tissue. Such results shed a beam of light on the opportunity of the parenteral implant polymeric nanocarrier system in providing a more sustainable controlled delivery of the drug for longer periods, over two weeks, in contrast to the transdermal nanoemulsion system that can last just for certain days, noteworthy both systems helped in limiting the inconvenient drawbacks accompanied with the oral dosage form.
Keywords:
Parenteral route, polymers implant nanoparticles, transdermal nanoemulsion, characterization, sustained prolonged effectDownloads
References
Ammar HO, Badawi AA, Mostafa DM and Abou - Taleb SA : Novel microemulsions as transdermal delivery s ystems for enhanced efficacy of fluoxetine hydrochloride. AJPSR, 2012; 2 (4): 1 - 16 .
Darshan KP and Tapash KG : Feasibility of transdermal delivery of fluoxetine. AAPS Pharm Sci Tech, 2005; 6: E144 - E149 .
Trotta M, Morel S and Gasco MR : Effect of oil p hase composition on the skin permeation of felodipine from o/w microemulsions. Pharmazie, 1997; 52: 50 - 53.
Kreilgaard M, Pedersen EJ and Jaroszewski JW : NMR characterisation and transdermal drug delivery potential of microemulsion systems. J Control Re lease, 2000; 69: 421.
He C, Kim SW and Lee DS : In situ gelling stimuli - sensitive block copolymer hydrogels for drug. J Control Release, 2008; 127(3): 189 - 207.
Tice TR and Tabibi ES : Parenteral drug: injectables. In: Kydonieus A. (Ed.), Treatise on co ntrolled drug: Fundamentals optimization, applications. New York: Marcel Dekker, 1991; 315 - 339 .
Tipton AJ and Fujita SM : A biodegradable injectable delivery system for nonsteroidal anti - inflammatory drugs. Pharm Res, 1991; 9: 196.
Bodmeier R : A met hod for in - situ production of particles. Pat Laid, D E Pat 197 24 784, 1997; 197(24): 784.
Kranz H and Bodmeier R : A biodegradable in - situ forming system for controlled drug release. Pharm Sci, 1998; 1 (S1): 414.
Eliaz RE and Kost J : Characterizatio n of a polymeric PLGA - injectable implant system for controlled release of proteins. J Biomed Mater Res, 2000; 50: 388 - 396 .
Kranz H, Brazeau GA, Napaporn J, Martin RL, Millard W and Bodmeier R : Myotoxicity studies of injectable biodegradable in - situ for ming drug systems. Int J Pharm, 2001; 212: 11 - 18 .
Abolghasem J, Mohammad AAF and Ali S : Solubility prediction methods for drug/drug like molecules. Recent Pat Chem Eng, 2008; 1(3): 220 - 231.
Cilurzo F, Selmin F, Minghetti P, Adami M, Bertoni E, Laur ia S and Montanaril L : Injectability Evaluation: An Open Issue. AAPS Pharm Sci Tech, 2011; 12 (2): 604 - 609.
Langenbucher F and Lange B: Prediction of the application behavior of cosmetics from rheological measurements. Pharm Acta Helv, 1970; 45: 572.
Li P and Zhao L: Developing early formulations: practice and perspective. Int J Pharm, 2007; 341(1-2): 1-19.
Strickley RG: Solubilizing excipients in oral and injectable formulations. Pharm Res, 2004; 21(2): 201-230.
Hadgraft J: Skin: the final frontier. Int J Pharm, 2001; 224: 1-18.
Jelonek K, Kasperczyk J, Li S, Dobrzynski P, Janeczek H and Jarzabek B: Novel poly(L-lactide-co- ???? -caprolactone) matrices obtained with the use of Zr[Acac]4 as nontoxic initiator for longterm release of immunosuppressive drugs. BioMed Res Int, 2013; 10: 1-11.
Brodbeck KJ, Duarte AG and Shen T: Gel composition and methods. Alza Corporation: USA, US6468961 B1, 1998.
Ravivarapu HB, Lee H and DeLuca PP: Enhancing initial release of peptide from poly(d,l-lactide-co-glycolide) (PLGA) microspheres by addition of a porosigen and increasing drug load. Pharm Dev Technol, 2000; 5: 287-296.
Luan X and Bodmeier R: In situ forming microparticle system for controlled of leuprolide acetate: influence of the formulation and processing parameters. Eur J Pharm Sci, 2006; 27: 143-149.
Sun W, Xie C, Wang H and Hu Y: Specific role of polysorbate 80 coating on the targeting of nanoparticles to the brain. Biomater, 2004; 25: 3065-3071.
Jain RA, Rhodes CT, Railkar AM, Malick AW and Shah NH: Controlled release of drugs from a novel injectable in situ formed biodegradable PLGA microsphere system. J Microencap, 2000 (a); 17(3): 343-362.
Jain RA, Rhodes CT, Railkar AM, Malick AW and Shah NH: Controlled release of drugs from injectable in situ formed biodegradable PLGA microspheres: effect of various formulation variables. Eur J Pharm Biopharm, 2000 (b); 50(2): 257262.
Mainardes RM and Evangelista RC: PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution. Int J Pharm, 2005; 290 (1-2): 137 – 144.
Feng S and Huang G: Effects of emulsifiers on the controlled release of paclitaxel (Taxol®) from nanospheres of biodegradable polymers. J Contr Release, 2001; 71: 53 – 69.
Türk CTS, Bayindir ZS and Badilli U: Preparation of polymeric nanoparticles using different stabilizing agents. J Fac Pharm Ankara, 2009; 38(4): 257-286.
Douglas KL and Tabrizian M: Effect of experimental parameters on the formation of alginate-chitosan nanoparticles and evaluation of their potential application as DNA carrier. J Biomater Sci Polym Ed, 2005; 16: 43-56.
Gan Z, Yu D, Zhong Z, Liang Q and Jing X: Enzymatric degradation of poly(epsiloncaprolactone)/poly(dl-lactide) blends in phosphate buffer solution. Polym, 1999; 40: 2859-2862.
Nair LS and Laurencin CT: Polymers as Biomaterials for Tissue Engineering and Controlled Drug. Tissue Eng Adv Biochem Eng Biotechnol, 2006; 102: 47-90.
Mittal G, Sahana DK, Bhardwaj V and Ravi Kumar MNV: Estradiol loaded PLGA nanoparticles for oral administration: Effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo. J Control Release, 2007; 119(1): 77-85.
Hatefi A and Amsden B: Biodegradable injectable in situ forming drug systems. J Control Release, 2002; 80 (1-3): 9-28.
Kranz H: In situ forming biodegradable drug systems. College of Pharmacy, Freie university Berlin, Germany, PhD Thesis, 2000; 84-85.
Published
How to Cite
Issue
Section
Copyright (c) 2015 Sally A. Abou Taleb, Hussien O. Ammar, Alia A. Badawi, Dina M. Mostafa
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Journal of Innovations in Pharmaceutical and Biological Sciences is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Based on a work at